Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

12055-62-8

File Name: 12055-62-8.asp

                                        MATERIAL SAFETY DATA SHEET



I PRODUCT IDENTIFICATION

Trade Name: Holmium Oxide Formula: Ho2O3
CAS #: 12055-62-8


II HAZARDOUS INGREDIENTS

None


III PHYSICAL DATA

Boiling Point (oF): Melting Point (oF):
Not applicable Not applicable
Specific Gravity: 8.40 Vapor Density (air=1): Not applicable
% Volatiles by Weight: Not applicable Solubility in H2O: Insoluble
Appearance and Odor: Light orange solid (powder)/odorless


IV FIRE AND EXPLOSION HAZARDS DATA

Flash Point (Method used): N/A Flammable Limits: Upper: N/A Lower: N/A

Extinguishing Media: Not combustible. Use extinguishing method appropriate for surrounding fire.
Special Fire Fighting Procedures: Wear a NIOSH/MSHA approved self-contained breathing apparatus and full protective clothing.

Unusual Fire & Explosion Hazards: None


V HEALTH HAZARD INFORMATION

Exposure Limits in Air: (No specific TWA cited. Suggested TWA for particulates not otherwise regulated.)

Chemical Name: ACGIH (TLV): OSHA (TWA):
10 mg/m3 15 mg/m3
Particulates
not otherwise (TWA) total dust
5 mg/m3 respirable
regulated total dust

Carcinogenicity: This product does not contain any ingredient designated by IARC, NTP, ACGIH or OSHA as a probable human
carcinogen.

Significant Laboratory Data with Possible Relevance to Man: No additional data found.
Medical Conditions Possibly Aggravated by Overexposure: None found.

Effects of Over Exposure: Swallowing: LOW ACUTE ORAL TOXICITY. For holmium oxide, the acute oral/rat LD50 is greater
than 1000 mg/kg.

Skin Absorption: LOW ACUTE DERMAL TOXICITY. No data was found for this product, but, based on data for other rare earth
oxides, it is expected to have low acute dermal toxicity.

Inhalation: LOW ACUTE INHALATION TOXICITY. No data was found for this product, but based on data for other rare earth
oxides, it is expected to have low acute inhalation toxicity.
Skin Contact: NON-IRRITATING. No data was found for this product, but, based on data for other rare earth oxides, it is expected
to be non-irritating.

Effects of Repeated Overexposure: Long term inhalation of rare earth oxide dusts may lead to congestion, coughing, granuloma in
lungs and hemoglobanemia.

EMERGENCY AND FIRST AID PROCEDURES:

EYES: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes using an eyewash fountain. Lift upper
and lower lids and rinse well under them. Get medical attention if irritation develops or persists.
SKIN: In case of contact, immediately wash with soap and plenty of water for at least 5 minutes. Remove contaminated clothing and
shoes. Thoroughly clean contaminated clothing and shoes before reuse. Get medical attention if irritation develops or persists.
INHALATION: Remove from area of exposure. Get medical attention as needed.
INGESTION: If swallowed and victim is fully conscious, induce vomiting immediately by giving two glasses of water and sticking
finger down throat. GET IMMEDIATE MEDICAL ATTENTION.

Note to Physician: All treatments should be based on observed signs and symptoms of distress in the patient. Consideration should
be given to the possibility that overexposure to materials other than this product may have occurred. Treat symptomatically. No
specific information found.


VI REACTIVITY DATA

Stability: Stable
Incompatibility (Material to Avoid): Strong acids

Hazardous Decomposition Products: N/A
Hazardous Polymerization: Will not occur


VII SPILL OR LEAK PROCEDURES

Steps to Be Taken in Case Material Is Released or Spilled: Wear appropriate protective gear. Sweep up into appropriate container.
Avoid creating dusting conditions.

Waste Disposal Method: Dispose of in accordance with Local, State and Federal Waste Disposal Regulations.


VIII SPECIAL PROTECTION INFORMATION

Respiratory Protection (Specify Type): Use a NIOSH/MSHA approved dust mask under dusting conditions.
Ventilation: Provide adequate ventilation. Use local exhaust under dusting conditions.

Protective Clothing: Work clothing and gloves.
Eye Protection: Safety Glasses with side shields. DO NOT WEAR CONTACT LENSES.

Other Protective Equipment: Maintain a sink and eyewash fountain in the work area.
Regulatory Status: TSCA Inventory Status: Product is TSCA certified.

Transportation Status: DOT - Not regulated.
Reportable Quantity (RQ) under U.S. EPA CERCLA: Not listed.
Specifically Listed under SARA Title III: Not listed.
IX SPECIAL PRECAUTIONS

Warning Statements: Nuisance particulate. Chronic exposure to high concentrations may cause damage to mucous membranes and
respiratory tract.

SARA Title III Hazard Classification: Delayed (Chronic) Health Hazard.

Handling and Storage: Store in a cool, dry place in tightly closed containers. Avoid breathing dusts. Avoid direct or prolonged
contact with skin and eyes. Wash hands thoroughly after handling. Do not rub eyes with soiled hands. Do not eat, drink or smoke in
the work area.

Other Precautions: Dry powders can build static electricity charges when subjected to the friction of conveying, mixing or sliding.
To prevent ignition, provide adequate precautions, such as electrical grounding, or inert atmospheres when material is used in the
presence of flammable materials.


Issued By: S. Dierks
Dated: April 1993

ALL Chemical Analysis PAGES IN THIS GROUP
NAMECAS
7681-65-4.asp 7681-65-4 7553-56-2
1308-80-1.asp 1308-80-1
1317-38-0.asp 1317-38-0
20405-64-5.asp 20405-64-5
7440-50-8.asp 7440-50-8
1317-40-4.asp 1317-40-4
12019-52-2.asp 12019-52-2
12019-23-7.asp 12019-23-7
9002-84-0.asp 9002-84-0
espimetals_com_diammineplatinumnitride.asp N/A
espimetals_com_dysprosiumchloride.asp N/A
13569-80-7.asp 13569-80-7
espimetals_com_dysprosiumoxide.asp N/A
10025-75-9.asp 10025-75-9
13760-83-3.asp 13760-83-3
12159-66-9.asp 12159-66-9
13765-25-8.asp 13765-25-8
12008-06-9.asp 12008-06-9
10138-52-0.asp 10138-52-0
13765-26-9.asp 13765-26-9
10168-81-7.asp 10168-81-7 7697-37-2
25764-15-2.asp 25764-15-2
13450-88-9.asp 13450-88-9
13450-90-3.asp 13450-90-3
13450-91-4.asp 13450-91-4
13494-90-1.asp 13494-90-1
espimetals_com_galliumnitride.asp N/A
12024-21-4.asp 12024-21-4
12063-98-8.asp 12063-98-8
14024-24-7.asp 14024-24-7
12024-27-0.asp 12024-27-0
12024-14-5.asp 12024-14-5
7783-51-9.asp 7783-51-9
espimetals_com_goldacetate.asp N/A
866-84-2.asp 866-84-2 77-92-2
554-07-4.asp 554-07-4
13499-05-3.asp 13499-05-3
12656-74-5.asp 12656-74-5 11105-16-1
12055-23-1.asp 12055-23-1
13759-17-6.asp 13759-17-6
espimetals_com_hexachloroplatinicacid.asp N/A
13825-76-8.asp 13825-76-8
14483-18-2.asp 14483-18-2 7697-37-2
12055-62-8.asp 12055-62-8
1312-41-0.asp 1312-41-0
10025-82-8.asp 10025-82-8
espimetals_com_indiumnitrate.asp N/A
25617-98-5.asp 25617-98-5
1312-43-2.asp 1312-43-2
espimetals_com_indiumphosphide.asp N/A


HBCChem,Inc

Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory